Bal Pharma Limited Clarifies 18-Month Timeline for Utilization of Convertible Warrants Proceeds
Bal Pharma Limited provided a clarification regarding the timeline for the utilization of net proceeds associated with its preferential issue involving Convertible Warrants.The Company stated that the tenure for utilizing the net proceeds of the Convertible Warrants is 18 months from the date of allotment. This timeline is subject to the receipt of requisite in-principle approval from the Stock Exchanges.
In light of the clarification, Bal Pharma confirmed that there is no change to the objects of the Preferential Issue or the manner of utilization of the proceeds. The current communication serves solely to clarify this tentative 18-month tenure for the net proceeds.
BALPHARMA Stock Price Movement
As of 11:21 AM, shares of Bal Pharma Limited are edging higher to ₹86.00 as they gain 0.95% in live trading today. The stock has seen a volume of 967 shares so far into the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.